EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study

Shanzhi Gu, Yang Zhao, Haixiong Yan, Muzi Li, Guowen Li, Manping Huang, Zhengping Xiong, Bin Huang

Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-14

DOI: 10.2147/jhc.s625046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Shanzhi Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Vascular Surgery I, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomaintra-arterial locoregional therapylenvatinibnivolumabreal-world studytriple therapy

Autor:innen und Institutionen

  • Department of Interventional Vascular Surgery I, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China.
  • Department of Interventional Vascular Surgery II, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China.

Zitieren

APA

Gu, S., Zhao, Y., Yan, H., Li, M., Li, G., Huang, M., Xiong, Z., & Huang, B. (2026). Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s625046

Vancouver

Gu S, Zhao Y, Yan H, Li M, Li G, Huang M, et al. Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s625046

BibTeX
@article{Gu2026,
  author = {Gu, Shanzhi and Zhao, Yang and Yan, Haixiong and Li, Muzi and Li, Guowen and Huang, Manping and Xiong, Zhengping and Huang, Bin},
  title = {Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--14},
  doi = {10.2147/jhc.s625046}
}
Kostenlos starten →